CSI-Sydney: New technologies to treat chronic sinus infection [ 2014 - 2017 ]

Research Grant

Researchers: Prof Paul Young (Principal investigator) ,  A/Pr Cynthia Whitchurch ,  Prof Dale Bailey ,  Prof Daniela Traini ,  Prof Gregory King

Brief description Chronic sinus infection (CSI) is prevalent and results in severe discomfort and pain for many Australians; yet amazingly, has no specific cure or effective treatment. Our multi-disciplinary research team and an Australian health and medical research company, (AFT Pharmaceuticals) have partnered to develop a novel device that specifically targets the sinuses and a formulation capable for simultaneously removing mucus, dispersing biofilms and killing bacteria in the nasal cavities.

Funding Amount $AUD 412,213.87

Funding Scheme Development Grants

Notes Development Grant